- Home
- CPBI vs IMRX Comparison
CPBI vs IMRX Comparison
Compare CPBI & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPBI
- IMRX
- Stock Information
- Founded
- CPBI 2023
- IMRX 2008
- Country
- CPBI United States
- IMRX United States
- Employees
- CPBI N/A
- IMRX N/A
- Industry
- CPBI
- IMRX Biotechnology: Pharmaceutical Preparations
- Sector
- CPBI
- IMRX Health Care
- Exchange
- CPBI Nasdaq
- IMRX Nasdaq
- Market Cap
- CPBI 56.2M
- IMRX 62.7M
- IPO Year
- CPBI N/A
- IMRX 2021
- Fundamental
- Price
- CPBI $14.79
- IMRX $1.76
- Analyst Decision
- CPBI
- IMRX Buy
- Analyst Count
- CPBI 0
- IMRX 7
- Target Price
- CPBI N/A
- IMRX $12.20
- AVG Volume (30 Days)
- CPBI 1.6K
- IMRX 314.1K
- Earning Date
- CPBI 01-01-0001
- IMRX 03-04-2025
- Dividend Yield
- CPBI N/A
- IMRX N/A
- EPS Growth
- CPBI 29.70
- IMRX N/A
- EPS
- CPBI 1.62
- IMRX N/A
- Revenue
- CPBI $18,546,000.00
- IMRX N/A
- Revenue This Year
- CPBI N/A
- IMRX N/A
- Revenue Next Year
- CPBI N/A
- IMRX N/A
- P/E Ratio
- CPBI $9.13
- IMRX N/A
- Revenue Growth
- CPBI 13.73
- IMRX N/A
- 52 Week Low
- CPBI $9.96
- IMRX $1.00
- 52 Week High
- CPBI $15.50
- IMRX $7.68
- Technical
- Relative Strength Index (RSI)
- CPBI 53.54
- IMRX 40.02
- Support Level
- CPBI $14.64
- IMRX $1.70
- Resistance Level
- CPBI $14.80
- IMRX $1.92
- Average True Range (ATR)
- CPBI 0.14
- IMRX 0.09
- MACD
- CPBI 0.00
- IMRX -0.01
- Stochastic Oscillator
- CPBI 96.67
- IMRX 15.00
About CPBI Central Plains Bancshares Inc.
Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists primarily of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in our primary market area, as well as commercial real estate loans.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.